Vir Biotechnology (VIR) Research & Development (2018 - 2026)

Vir Biotechnology (VIR) has 9 years of Research & Development data on file, last reported at $108.9 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development fell 8.2% year-over-year to $108.9 million; the trailing twelve-month figure through Mar 2026 stood at $446.2 million (down 15.0% YoY), and the FY2025 full-year result was $456.0 million, down 9.98% from the prior year.
• Research & Development improved to $108.9 million in Q1 2026, from $88.3 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $195.2 million in Q3 2024 to a low of $88.3 million in Q4 2025.
• A 5-year average of $125.0 million and a median of $114.2 million in 2022 frame the typical range for Research & Development.
• Across the five-year window, Research & Development surged 74.72% in 2023 and tumbled 37.46% in 2024, its largest moves.
• Tracing VIR's Research & Development over 5 years: stood at $155.2 million in 2022, then decreased by 29.78% to $109.0 million in 2023, then declined by 2.65% to $106.1 million in 2024, then fell by 16.72% to $88.3 million in 2025, then grew by 23.29% to $108.9 million in 2026.
• Business Quant data shows VIR's Research & Development at $108.9 million in Q1 2026, $88.3 million in Q4 2025, and $151.5 million in Q3 2025.